Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype

checkorphan
Learn more about:
X-linked Hypohidrotic Ectodermal Dysplasia
Related Clinical Trial
Intraamniotic Administrations of ER004 in Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation Characterization of Sweat Gland Function in Patients With Recessively Inherited Hypohidrotic Ectodermal Dysplasia Sweat Duct Imaging in Mother/Newborn Dyads Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey Phenotypic Properties in Individuals Affected With XLHED Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status A Cross-Sectional Natural History Study to Evaluate Sweat Volume and Other Phenotypic and Genetic Characteristics in Patients Affected by XLHED A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200 Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal Dysplasia Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012) Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002 Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia – A

Brief Title

Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype

Official Title

Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype

Brief Summary

      This study is being done to collect information about people who have or may have
      Hypohidrotic Ectodermal Dysplasia (HED) or X-linked Hypohidrotic Ectodermal Dysplasia
      (XLHED). This study will allow Edimer Pharmaceuticals to know more about HED/XLHED so that
      hopefully the investigators can develop a drug to treat this condition. In this study Edimer
      will retrospectively review and abstract (summarize) medical records of people that have or
      may have HED/XLHED in order to further understand the natural history and disease
      characteristics.

Study Type

Observational

Condition

Hypohidrotic Ectodermal Dysplasia

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Estimated Enrollment

11

Start Date

April 2011

Eligibility Criteria

        Inclusion Criteria:

        -Males or females with:

          1. the clinical characteristics of HED, including at least two of the following
             characteristics: a history of decreased sweating;abnormal teeth (fewer permanent
             teeth, teeth are smaller than average and often have conical crowns);sparseness of
             scalp and body hair.

             -OR-

          2. genetically confirmed HED or XLHED;

Gender

All

Ages

N/A - N/A

Accepts Healthy Volunteers

No

Contacts

, ,

Location Countries

United States

Location Countries

United States

Administrative Informations

NCT ID

NCT01398397

Organization ID

ECP-006

Responsible Party

Sponsor

Study Sponsor

Edimer Pharmaceuticals

Collaborators

 National Foundation of Ectodermal Dysplasia

Study Sponsor

, ,

Verification Date

June 2012